1-888-9-ASSURX | Sitemap | Blog | Follow Us on Twitter | Contact Us

Status Report: Electronic Medical Device Reporting (eMDR) | Updates for the Medical Device Industry

Please visit the AssurX Blog for the latest updates on eMDR.


October 7, 2008

No definitive release date for eMDR draft guidance documents from the FDA

In a recent Webcast, Indira Konduri of the FDA indicated that they were still working on the proposed rule making for electronic medical device reporting (eMDR). No specific time line has been released. However, she did hint that the time frame to implement (if mandated) would most likely be one year. As with any other proposed guidance, there will be an open public comment period.

Another FDA insider told us that the guidance documents would either be released at the end of this year, or early 2009. Original scheduled release date was 2Q of 2008. We'll keep you posted as soon as we find out.


August 3, 2008

Report Demonstrates need for Trans-Manufacturer eMDR System

Each year medical device manufacturers, doctors, hospitals and patients waste billions of dollars on medical treatments that don’t work – but many of those could be prevented if the FDA instituted a mandatory electronic Medical Device Reporting (eMDR) tracking system that could be used by all manufacturers.

“The FDA, device manufacturers and industry partners should be able to come together to create and use such a system,” commented AssurX Vice President, Tamar June.

A recent article in The New York Times (“A Call for a Warning System on Artificial Joints,” July 29, 2008) reported that the United States wastes “billions of dollars annually on medical treatments which may not work.” It also notes that the “financial and human consequences are also large when evidence exists [about a device’s problem or potential problem] but is not collected.”

“We are No. 1 both as a provider and user of implants,” a doctor and professor of orthopedics told The Times. “We should be the leader in the follow-up of them.”

However, the best solution is not the creation of another inert database.

“Instead of creating another burdensome national database of complaints and other issues, everyone would be better served if the FDA established a means to accept that information electronically from all device manufacturers,” June noted. With that kind of system in place, the FDA could easily do trends based on the type of medical device and its use, e.g. all hip replacements by all manufacturers to identify CAPA trends and potential problems before they get serious.


April 18, 2008

Update from the FDA provided by www.eDataIntegrityReport.com

eMDR Regulation Slow, But Guidance "Nearly Complete"

A recent article and eblast in eDataIntegrityReport quoted FDA electronic Medical Device Reporting (eMDR) point man Stephen Sykes as saying that the eMDR "guidance" was moving "slowly through the government bureaucracy" and won't be coming out soon. However, Sykes has corrected us to note that it is actually the regulation that is moving slowly thru the review process. "The guidance, however, is nearly complete, and the technical documentation for the system is available now" Sykes told EDIR this week.

Sykes is Deputy Director, Office of Surveillance and Biometrics, Center for Devices and Radiological Health at the FDA.


April 2008

eMDR Webinar to be held May 8, 2008 - 10 am PT | 1pm ET

Inefficient medical device reporting presents a clear and present danger: It can damage your company’s reputation and even threaten your ability to operate. After sending some mixed signals in the second half of 2007, FDA eMDR experts have said they’ll mandate eMDR within two years. The only debate now is how quickly it will happen, and what kind of extension smaller device companies may get.

For more information about this free webinar, click here.


March 2008

Update from the FDA provided by www.eDataIntegrityReport.com

eMDR: Stalled, but not forgotten?

The FDA’s point-person on the electronic Medical Device Reporting (eMDR) initiative just told us that the guidance won’t be coming out this month as hoped – and it’s anybody’s guess when it will finally emerge.

“It’s going slowly through the government bureaucracy,” said Steve Sykes, Deputy Director, Office of Surveillance and Biometrics with the Center for Devices and Radiological Health (CDRH), in an exclusive interview with EDIR March 26. He said that the delay should not be interpreted as the FDA losing interest in the project. “I’m disappointed” by the pace, he added.

However, Sykes said he hoped medical device companies would soon embrace the eMDR initiative regardless of a guidance being issued for comment. “We’re ready to receive,” he said. On the downside, there have not been any additional device companies or other industry players who have asked the FDA to participate since the initial companies came forward last year, he said.

The reason? “I think part of it is that medical device companies are using this as an opportunity to revamp their entire Adverse Events systems, rather than just hook in with the FDA’s eMDR program now.”

“It’s at least 18 months away” from being made mandatory, Sykes told us at the end of 2007. He still hopeful on a rough timetable that goes something like this: The agency will issue draft guidance in the first half of 2008, take comments for 90 days, and then issue a final rule that will mandate eMDR within a year of the final rule coming out.


February 2008

AssurX eMDR preview event a tremendous success! Customers and prospects comment on the solution:

"I really love the look/feel/ease of use for the new eMDR solution."

"Once again, the AssurX team and their product establishes and maintains superiority over the rest."

"I really do think the eMDR solution AssurX created is super slick!"

Want to see for yourself? Request to view the recorded demo.


January 2008

AssurX releases a new, informative eBook on eMDR

Request your eMDR eBook Today! "Leveraging the Benefits of eMDR: A Guide to Taking Advantage of eMDR to Improve your Operations"– This complimentary eBook goes into detail about how eMDR works, what the FDA says about eMDR, and the benefits of adopting this technology through developing an effective strategy. Request your eMDR eBook today!

December 2007

AssurX eMDR (Electronic Medical Device Reporting) Update:
Due to the overwhelming amount of questions we get asked about our upcoming eMDR (Electronic Medical Device Reporting) solution, we’ve put together this Q&A to let you know what we’ve been up to:

Question: Is AssurX going to have an eMDR (Electronic Medical Device Reporting) solution?
Answer: Yes

Question: When will it be available?
Answer: AssurX doesn’t pre-announce product launch dates. But what we can say is we’ll be ready with eMDR when the FDA is ready to receive them through their AS2 production system. Currently they are still in testing stage, and haven’t gone live.

Question: Are you currently testing the eMDR system with the FDA?
Answer: Yes. In fact, we’ve also helped them solve a few irregularities with XML translation files, which have in turn helped all the vendors participating in this program.

Question: Has your testing been successful?
Answer: Yes, as we’ve hit all the milestones including receiving all acknowledgements, etc., from the FDA.

Question: Has anyone seen your system?
Answer: Yes, we did a live demonstration at our AssurX Summit user conference to all of our customers in attendance back in September 2007.

Question: Do you have customers who are testing the system as well?
Answer: Yes, we have several who are on board for testing.

Question: Other vendors are touting they’ve been working closely with the FDA. Has AssurX been doing the same?
Answer: Yes, we’ve been working with the FDA all along. We’ve also helped solve several irregularities we’ve found along the way. See above.

Questions: Do you think the FDA will make eMDR mandatory?
Answer: Maybe. We’ll have to wait and see what happens after the comment period scheduled for Q1 next year.

If you have any further questions, please feel free to contact Tamar M. June, VP of Marketing at 408-778-1376, ext. 705.

If you would like to be kept up to date about eMDR at AssurX, please send us an email at emdr@assurx.com.




eMDR Webinar


NEW! More information about AssurX eMDR - Click Here

NEW! AssurX eMDR Product Demonstration
Request Recorded Event

NEW Read more about the FDA's current eMDR program here

eMDR will be part of AssurX's medical device complaint handling and regulatory reporting system

AssurX has met every milestone and is finished testing the system wth the FDA

AssurX demonstrated the eMDR system live at the AssurX Summit user conference early September 2007

For more information about the FDA's Electronic Gateway Submission program, please visit:

http://www.fda.gov/esg




AssurX OnDemand

E-mail Us

AssurX, Inc.
18525 Sutter Boulevard
Suite 150
Morgan Hill, CA 95037
Tel: 408-778-1376
Copyright 1993 - 2010.
All rights reserved.